IL-17D polyclonal biotin, anti-human

Source:
Produced from sera of rabbits immunized with highly pure recombinant Human IL-17D. Anti-Human IL-17D specific antibody was purified by affinity chromatography and then biotinylated.

Western Blot:
To detect Human IL-17D by Western Blot analysis this antibody can be used at a concentration of 0.1 - 0.2 mg/ml. when used in conjunction with compatible development reagents the detection limit for recombinant Human IL-17D is 1.5 / 3.0 ng/lane, under either reducing or non-reducing conditions.

Sandwich ELISA:
To detect Human IL-17D by sandwich ELISA (using 100 ml/well) a concentration of 0.25 / 1.0 μg/ml of this antibody is required. This biotinylated polyclonal antibody, in conjunction with BioGems Polyclonal Anti- Human IL-17D (60-017DP) as a capture antibody, allows the detection of at least 0.2 - 0.4 ng/well of recombinant Human IL-17D.

Direct ELISA:
To detect Human IL-17D by direct ELISA (using 100 ml/well) a concentration of approximately 1.0 μg/ml of this antibody is required. This biotinylated polyclonal antibody allows the detection of at least 0.2 - 0.4 ng/well of recombinant Human IL-17D.

Formulation: A sterile filtered antibody solution was lyophilized from PBS, pH 7.2.

Reconstitution: Centrifuge vial prior to opening. Reconstitute in sterile PBS containing 0.1% BSA to a concentration of 0.1-1.0 mg/ml.